Mark Meltz
Geen lopende functies
Profiel
Mark Adam Meltz worked as an Associate General Counsel at Biogen, Inc. from 2007 to 2012.
He then served as the Chief Business Development & Legal Officer at Emergent Travel Health, Inc. from 2014 to 2019.
Mark also worked as Counsel at BMC Partners LLP and as the Head-North & Latin America Legal Division at Novartis Vaccines & Diagnostics, Inc. In 2019, he became the Senior Vice President & General Counsel at Astellas Gene Therapies, Inc. until 2020.
Currently, Mark is the COO, Secretary, Treasurer & General Counsel at Kinnate Biopharma, Inc. starting from 2021.
He completed his undergraduate studies at Yale University and obtained his graduate degree from Boston College Law School.
Eerdere bekende functies van Mark Meltz
| Bedrijven | Functie | Einde |
|---|---|---|
| KINNATE BIOPHARMA INC. | Financieel Directeur/CFO | 07-06-2021 |
| AUDENTES THERAPEUTICS, INC. | Algemeen Adviseur | 01-02-2020 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Algemeen Adviseur | 01-03-2019 |
| BIOGEN INC. | Algemeen Adviseur | 01-03-2012 |
BMC Partners LLP
 BMC Partners LLP Miscellaneous Commercial ServicesCommercial Services BMC Partners LLP provides litigation, corporate, finance, restructuring, employment and benefits, and intellectual property services in all industries. It also offers consulting and advisory services in government, investment management, and mergers and acquisitions. The company was founded on July 1, 2002 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Opleiding van Mark Meltz
| Boston College Law School | Graduate Degree |
| Yale University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
BMC Partners LLP
BMC Partners LLP Miscellaneous Commercial ServicesCommercial Services BMC Partners LLP provides litigation, corporate, finance, restructuring, employment and benefits, and intellectual property services in all industries. It also offers consulting and advisory services in government, investment management, and mergers and acquisitions. The company was founded on July 1, 2002 and is headquartered in Boston, MA. | Commercial Services |